Two major diabetes tech companies, Dexcom and Insulet, are making changes to their C-suites.  | The changes at the diabetes tech companies include Dexcom announcing that outgoing CEO Kevin Sayer is ...

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

Brands succeed by appealing to both the functional benefits of a product and a person’s identity and aspirations.

Strapping on an insulin pump may not always feel heroic, but Insulet and Marvel are changing that narrative with a new comic ...

Oppenheimer assumed coverage of Insulet (PODD) with an Outperform rating and price target of $365, up from $324. The firm updated the company’s ...

Weddings are all about happiness moments filled with love, laughter, and being together. Yet sometimes, under the gleaming ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the appointment of Eric ...

In partnership with data partner Plant A, Newsweek ranks America's Greatest Companies, where health care-related companies shine.

[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced ...

Q2 revenue rises 32.9% Y/Y to $649.1 million, beating estimates and topping guidance range. Insulet raises FY25 sales outlook to $2.57 billion–$2.63 billion, above prior view of $2.47 billion–$2.53 ...

A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said. Certain types of speakers in Tandem’s devices have a higher risk of malfunction, which ...

The MODD1 insulin pump. [Image from Modular Medical] Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in the U.S. San ...